Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI

Neurobiology of Aging

Volumn 25, Issue 4, 2004, Pages 465-474

  Berlin, Daniel ^a,b   Chong, George ^c   Chertkow, Howard ^a,b,d   Bergman, Howard ^a,b,d   Phillips, Natalie A ^a,d,e   Schipper, Hyman M ^a,b,d  

^a Bloomfield Centre for Research in Aging   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d Ctr for Neurotranslational Research   (Canada)

^e Gina Cody School of Engineering and Computer Science   (Canada)

Author keywords

Alzheimer disease; Hemochromatosis; Hfe mutation; Iron; Mild cognitive impairment

Indexed keywords

APOLIPOPROTEIN E;

ACCELERATION; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BIOACCUMULATION; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; DEMOGRAPHY; DNA MODIFICATION; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MEDICAL ASSESSMENT; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN INTERACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; WILD TYPE; ZYGOSITY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; FEMALE; GENETIC MARKERS; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; NEUROPSYCHOLOGICAL TESTS;

EID: 1542328195     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2003.06.008     Document Type: Article

References (25)

1. Brittenham G.M., Cohen A.R., McLaren C., Martin M.B., Griffith P.M., Nienhuis A.W.et al. Hepatic iron stores and plasma ferritin concentrations in patients with sickle cell anemia and thallasemia major. Am. J. Hematol. 42:1993;81-85.
2. Chertkow H., Bergman H., Schipper H.M., Gauthier S., Bouchard R., Fontaine S.et al. Assessment of suspected dementia. Can. J. Neurol. Sci. 28(Suppl. 1):2001;S28-S41.
3. Connor J.R., Milward E.A., Moalem S., Sampietro M., Boyer P., Percy M.E.et al. Is hemochromatosis a risk factor for Alzheimer disease? J. Alzheimer's Dis. 3:2001;471-477.
4. Connor J.R., Snyder B.S., Arosio P., Loeffler D.A., LeWitt P. A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J. Neurochem. 65:1995;717-724.
5. Ehmann W.D., Markesbery W.R. Brain trace elements in Alzheimer's disease. Neurotoxicology. 7:1986;197-206.
6. Feder J.N., Gnirke A., Thomas W., Tsuchihashi Z., Ruddy D.A., Basava A. et al. A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13:1996;399-408.
7. Feder J.N., Penny D.M., Irrinki A., Lee V.K., Lebron J.A., Watson N. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc. Natl. Acad. Sci. U.S.A. 95:1998;1472-1477.
8. Folstein M., Folstein F., McHugh P. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J. Clin. Res. 12:1975;189-198.
9. Hixon J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31:1990;545-548.
10. Hughes C.P., Berg L., Danziger W.L., Coben L.A., Martin R.L. A new clinical scale for the staging of dementia. Br. J. Psychiatry. 140:1982;566-572.
11. Jazwinska E.C. Hemochromatosis: a genetic defect in iron metabolism. BioEssays. 20:1998;562-568.
12. Jefferies W.A., Food M.R., Gabathuler R., Rothenberger S., Yamada T., Yasuhara O.et al. Reactive microglia specifically associated with amyloid plaques in Alzheimer's disease brain tissue express melanotransferrin. Brain Res. 712:1996;122-126.
13. Kalaria R.N., Sromek S.M., Grabovac I., Hank S.I. Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease. Brain Res. 585:1992;87-93.
14. Leveugle B., Spik G., Peri D.B., Bouras C., Fillit H.M., Hof P.R. The iron binding protein lactotransferrin is present in pathologic lesions in a variety of neurodegenerative disorders: a comparative immunohistochemical analysis. Brain Res. 650:1994;20-31.
15. Lyon F., Frank E.L. Hereditary hemochromatosis since discovery of the HFE gene. Clin. Chem. 47:2001;1147-1156.
16. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1997;134-147.
17. McKhann G., Drachman D., Fostein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;939-944.
18. Merryweather-Clarke A.T., Pointon J.J., Shearman J.D., Robson K.J.H. Global prevalence of putative haemochromatosis mutations. J. Med. Genet. 34:1997;275-278.
19. Moalem S., Percy M.E., Andrews D.F., Knick T.P.A., Wong S., Dalton A.J. et al. Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am. J. Med. Genet. 93:2000;58-66.
20. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 56:1999;303-308. [Erratum: Arch Neurol 1999;56:760].
21. Pinero D.J., Hu J., Connor J.R. Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains. Cell. Mol. Biol. 46:2000;761-776.
22. Sampietro M., Caputo L., Casatta A., Meregalli M., Pellagaffi A., Tagliabue J.et al. The hemochromatosis gene affects the age of onset of sporadic Alzheimer's disease. Neurobiol. Aging. 22:2001;563-568.
23. Schipper HM. Glial iron sequestration and neurodegeneration. In: Schipper HM, editor. Astrocytes in brain aging and neurodegeneration. Austin: Landes; 1998. p. 235-51.
24. Schipper H.M., Cissé S., Stopa E.G. Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain. Ann. Neurol. 37:1995;758-768.
25. Strittmatter W.J., Saunders A.M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G.S.et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90:1993;1977-1981.